Baird reiterates an Outperform rating on Amgen Inc. (Nasdaq: AMGN). New price target $70.

Baird analyst says, "While we understand ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE